The Trump administration is developing a drug to protect against the threat of the opioid fentanyl being used in a terrorist attack.

The Department of Health and Human Services said Thursday that the new drug it was working on, know as nalmefene, was intended not only to prevent the reported 40,000 deaths a year from the opioid crisis, but as a safeguard in case fentanyl is used in a terrorist attack.